Viz.ai Stock

HealthTech

Looking to sell Viz.ai stock or options?

Founded: 2016Funding to Date: $293M

Viz.ai, a developer of a smart care coordination platform, is dedicated to revolutionizing global healthcare delivery. The company's platform harnesses the power of advanced deep learning to relay critical information about stroke patients directly to a specialist who can provide immediate treatment. This enables healthcare providers to decrease treatment times and enhance patient access to care.

Investors include:

Further Key Investors:

Susa Ventures, Greenoaks Capital Partners, AME Cloud Ventures, Seedcamp, Kevin Ding, Threshold Ventures, Jukka Jokinen, Halle Tecco, Scale Venture Partners, GV, CRV, Pear (California), DHVC, Geodesic Capital, Tiger Global Management, J Mocco, Canadian Imperial Bank of Commerce, Hakluyt Capital, Innovation Endeavors, Sozo Ventures.

Our available services for this company

Lifetime IncomeCharitable Remainder Trust

Tax SavingsDonor Advised Fund

Management Team

Gad SakinChief Product Officer and General Manager

Chief Product Officer and General Manager

Manoj RamachandranCo-Founder

Co-Founder

Lisa GarlandVice President of Finance

Vice President of Finance

Kurt BlasenaChief Revenue Officer

Chief Revenue Officer

David GolanCo-Founder & Board Member

Co-Founder & Board Member

Julie SkaffChief Operating Officer

Chief Operating Officer

Jayme StraussChief Clinical Officer

Chief Clinical Officer

David KiznerChief Privacy Officer & General Counsel

Chief Privacy Officer & General Counsel

Jieun ChoeChief Marketing Officer

Chief Marketing Officer

Christopher Mansi MDCo-Founder, Chief Executive Officer & Board Member

Co-Founder, Chief Executive Officer & Board Member

Thomas KrohnGlobal Pharma Commercial Lead

Global Pharma Commercial Lead

Jacob SchiftanSenior Director of Product Management

Senior Director of Product Management

William StadtlanderVice President, Global Med Tech Commercial Lead

Vice President, Global Med Tech Commercial Lead

Steve SweenyVice President, Business Development and Strategy

Vice President, Business Development and Strategy

Anne HellieSenior Director of Strategic Engagement

Senior Director of Strategic Engagement

Eric LubbersVice President Strategic Accounts & Sales Operations

Vice President Strategic Accounts & Sales Operations

Nina BinettiVice President, Product and Lifescience Marketing

Vice President, Product and Lifescience Marketing

Board Members

Neil ShahBoard Member

Board Member

Mamoon HamidBoard Member

Board Member

Rory O'DriscollBoard Member

Board Member

Kevin DingBoard Member

Board Member

Other HealthTech companies from Collective's Target Portfolio

Companies backed by the same VC's

Viz.ai in the News

Source: 01netViz.ai and Medtronic Collaborate to Improve Post-Acute Stroke Patient Care in the United States

Collaboration aims to help cryptogenic stroke patients receive necessary cardiology follow-up to reduce risk of secondary strokeSAN FRANCISCO--(BUSINESS

Source: 01netViz.ai Receives FDA 510(k) Clearance for Artificial Intelligence Algorithm for the Quantification of Intracerebral Hemorrhage

New AI algorithm enables precise and reliable quantification of intracerebral hemorrhage to make accurate and timely treatment decisionsSAN

Source: Medical Device NetworkViz.ai’s aneurysm diagnostic tool is 97.2% predictive in ruling out stroke

The AI-powered diagnostic platform can diagnose the presence of aneurysms by analysing computed tomography (CT) scans.

Source: ForbesHow Viz.ai Uses Artificial Intelligence To Treat Stroke Patients Faster

The startup has 12 FDA-approved algorithms, agreements with more than 1,500 U.S. hospitals, and plans to work with drug companies to reduce healthcare roadblocks.

Source: Business WireViz.ai Launches AI-Powered Viz™ Vascular Suite

SAN FRANCISCO--(BUSINESS WIRE)-- #ai--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced the launch of VizTM Vascular Suite, AI-powered software enabling vascular care teams to automatically detect and triage…

Source: Business WireViz.ai Wins Four Comparably Awards for Best Place to Work

SAN FRANCISCO--(BUSINESS WIRE)-- #ai--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, has received two additional Comparably Best Place to Work Awards for Best Company Culture and Best Company for Diversity in 2022. Earli…

Source: Business WireViz.ai and Cercare Medical Partner to Support Neurovascular Clinical DecisionMaking

SAN FRANCISCO--(BUSINESS WIRE)-- #ai--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced a partnership with Cercare Medical, which delivers next-level medical imaging with CT and MRI. The partnership will inc…

Source: Business WireViz.ai Appoints Radiology Advisory Board to Advance Innovation

SAN FRANCISCO--(BUSINESS WIRE)-- #ai--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced the creation of its Radiology Advisory Board to assist Viz.ai in the development of strategy and products to support ra…

Source: Business WireViz.ai and Vastrax Join Forces to Accelerate Clinical Trial Enrollment

SAN FRANCISCO--(BUSINESS WIRE)-- #AI--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced a strategic partnership with Vastrax, the leading full-service, vascular clinical research organization (CRO). Together…

Source: Business WireViz.ai Launches AI-Powered VizTM Cardio Suite

CHICAGO & SAN FRANCISCO--(BUSINESS WIRE)-- #AHA2022--AMERICAN HEART ASSOCIATION SCIENTIFIC SESSIONS-- Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced the launch of a full cardiology suite to speed and impr…